Altered ADAR 2 equilibrium and 5HT 2CR editing in the prefrontal cortex of ADAR 2 transgenic mice

Genes, Brain and Behavior

Volumn 10, Issue 6, 2011, Pages 637-647

  Singh, M ^a   Singh, M M ^a,b   Na, E ^b   Agassandian, K ^d   Zimmerman, M B ^c   Johnson, A K ^b,d,e  

^a UNIVERSITY OF IOWA   (United States)

^b E11 SSH   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

ADAR2; Behavioral despair; ERK signal and 5HT 2CR; RNA editing

Indexed keywords

ASPARAGINE; BRAIN DERIVED NEUROTROPHIC FACTOR; COMPLEMENTARY DNA; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HYDROLASE; ISOLEUCINE; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN ADAR1; PROTEIN ADAR2; PROTEIN ADAR3; SEROTONIN; SEROTONIN 2C RECEPTOR; UNCLASSIFIED DRUG; VALINE;

AMINO ACID ANALYSIS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; GENE EXPRESSION; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; MALE; MOOD DISORDER; MOUSE; NEUROMODULATION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EDITING; SIGNAL TRANSDUCTION; TRANSGENE; TRANSGENIC MOUSE; WESTERN BLOTTING;

ADENOSINE DEAMINASE; ANIMALS; BEHAVIOR, ANIMAL; DEPRESSION; MICE; MICE, TRANSGENIC; PREFRONTAL CORTEX; RECEPTOR, SEROTONIN, 5-HT2C; RNA EDITING; RNA, MESSENGER;

MUS MUSCULUS;

EID: 79961028650     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/j.1601-183X.2011.00701.x     Document Type: Article

References (70)

1. Abbas, A.I., Urban, D.J., Jensen, N.H., Farrell, M.S., Kroeze, W.K., Mieczkowski, P., Wang, Z. & Roth, B.L. (2010) Assessing serotonin receptor mRNA editing frequency by a novel ultra high-throughput sequencing method. Nucleic Acids Res 38, e118.
2. Beal, P.A., Maydanovych, O. & Pokharel, S. (2007) The chemistry and biology of RNA editing by adenosine deaminases. Nucleic Acids Symp Ser (Oxf), 51, 83-84.
3. Berg, K.A., Cropper, J.D., Niswender, C.M., Sanders-Bush, E., Emeson, R.B. & Clarke, W.P. (2001) RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity. Br J Pharmacol 134, 386-392.
4. Berg, K.A., Clarke, W.P., Cunningham, K.A. & Spampinato, U. (2008) Fine-tuning serotonin2c receptor function in the brain: molecular and functional implications. Neuropharmacology 55, 969-976.
5. Burnashev, N., Monyer, H., Seeburg, P.H. & Sakmann, B. (1992) Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron 8, 189-198.
6. Burns, C.M., Chu, H., Rueter, S.M., Hutchinson, L.K., Canton, H., Sanders-Bush, E. & Emeson, R.B. (1997) Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 387, 303-308.
7. Chen, C.X., Cho, D.S., Wang, Q., Lai, F., Carter, K.C. & Nishikura, K. (2000) A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. RNA 6, 755-767.
8. Dracheva, S., Elhakem, S.L., Marcus, S.M., Siever, L.J., McGurk, S.R. & Haroutunian, V. (2003) RNA editing and alternative splicing of human serotonin 2C receptor in schizophrenia. J Neurochem 87, 1402-1412.
9. Dracheva, S., Chin, B. & Haroutunian, V. (2008a) Altered serotonin 2C receptor RNA splicing in suicide: association with editing. Neuroreport 19, 379-382.
10. Dracheva, S., Patel, N., Woo, D.A., Marcus, S.M., Siever, L.J. & Haroutunian, V. (2008b) Increased serotonin 2C receptor mRNA editing: a possible risk factor for suicide. Mol Psychiatry 13, 1001-1010.
11. Du, Y., Davisson, M.T., Kafadar, K. & Gardiner, K. (2006) A-to-I pre-mRNA editing of the serotonin 2C receptor: comparisons among inbred mouse strains. Gene 382, 39-46.
12. Dwivedi, Y., Rizavi, H.S., Roberts, R.C., Conley, R.C., Tamminga, C.A. & Pandey, G.N. (2001) Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J Neurochem 77, 916-928.
13. Englander, M.T., Dulawa, S.C., Bhansali, P. & Schmauss, C. (2005) How stress and fluoxetine modulate serotonin 2C receptor pre-mRNA editing. J Neurosci 25, 648-651.
14. Feng, Y., Sansam, C.L., Singh, M. & Emeson, R.B. (2006) Altered RNA editing in mice lacking ADAR2 autoregulation. Mol Cell Biol 26, 480-488.
15. Fitzgerald, L.W., Iyer, G., Conklin, D.S., Krause, C.M., Marshall, A., Patterson, J.P., Tran, D.P., Jonak, G.J. & Hartig, P.R. (1999) Messenger RNA editing of the human serotonin 5-HT2C receptor. Neuropsychopharmacology 21, 82S-90S.
16. Frey, B.N., Andreazza, A.C., Nery, F.G., Martins, M.R., Quevedo, J., Soares, J.C. & Kapczinski, F. (2007) The role of hippocampus in the pathophysiology of bipolar disorder. Behav Pharmacol 18, 419-430.
17. Gardiner, K. & Du, Y. (2006) A-to-I editing of the 5HT2C receptor and behaviour. Brief Funct Genomic Proteomic 5, 37-42.
18. Grippo, A.J., Na, E.S., Johnson, R.F., Beltz, T.G. & Johnson, A.K. (2004) Sucrose ingestion elicits reduced Fos expression in the nucleus accumbens of anhedonic rats. Brain Res 1019, 259-264.
19. Gurevich, I., Englander, M.T., Adlersberg, M., Siegal, N.B. & Schmauss, C. (2002a) Modulation of serotonin 2C receptor editing by sustained changes in serotonergic neurotransmission. J Neurosci 22, 10529-10532.
20. Gurevich, I., Tamir, H., Arango, V., Dwork, A.J., Mann, J.J. & Schmauss, C. (2002b) Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron 34, 349-356.
21. Hackler, E.A., Airey, D.C., Shannon, C.C., Sodhi, M.S. & Sanders-Bush, E. (2006) 5-HT(2C) receptor RNA editing in the amygdala of C57BL/6J, DBA/2J, and BALB/cJ mice. Neurosci Res 55, 96-104.
22. Hardingham, G.E., Arnold, F.J. & Bading, H. (2001) A calcium microdomain near NMDA receptors: on switch for ERK-dependent synapse-to-nucleus communication. Nat Neurosci 4, 565-566.
23. Hartner, J.C., Schmittwolf, C., Kispert, A., Muller, A.M., Higuchi, M. & Seeburg, P.H. (2004) Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J Biol Chem 279, 4894-4902.
24. Higuchi, M., Maas, S., Single, F.N., Hartner, J., Rozov, A., Burnashev, N., Feldmeyer, D., Sprengel, R. & Seeburg, P.H. (2000) Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 406, 78-81.
25. Iwamoto, K. & Kato, T. (2003) RNA editing of serotonin 2C receptor in human postmortem brains of major mental disorders. Neurosci Lett 346, 169-172.
26. Iwamoto, K., Bundo, M. & Kato, T. (2005a) Estimating RNA editing efficiency of five editing sites in the serotonin 2C receptor by pyrosequencing. RNA 11, 1596-1603.
27. Iwamoto, K., Nakatani, N., Bundo, M., Yoshikawa, T. & Kato, T. (2005b) Altered RNA editing of serotonin 2C receptor in a rat model of depression. Neurosci Res 53, 69-76.
28. Kozak, M. (1980) Evaluation of the "scanning model" for initiation of protein synthesis in eucaryotes. Cell 22, 7-8.
29. Labasque, M., Meffre, J., Carrat, G., Becamel, C., Bockaert, J. & Marin, P. (2010) Constitutive activity of Serotonin2C receptors at G protein-independent signaling: modulation by RNA editing and antidepressants. Mol Pharmacol 78, 818-826.
30. Lan, M.J., McLoughlin, G.A., Griffin, J.L., Tsang, T.M., Huang, J.T., Yuan, P., Manji, H., Holmes, E. & Bahn, S. (2009) Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder. Mol Psychiatry 14, 269-279.
31. Lee, H.J., Kim, J.W., Yim, S.V., Kim, M.J., Kim, S.A., Kim, Y.J., Kim, C.J. & Chung, J.H. (2001) Fluoxetine enhances cell proliferation and prevents apoptosis in dentate gyrus of maternally separated rats. Mol Psychiatry 6, 725-618.
32. Lehmann, K.A. & Bass, B.L. (1999) The importance of internal loops within RNA substrates of ADAR1. J Mol Biol 291, 1-13.
33. Lehmann, K.A. & Bass, B.L. (2000) Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities. Biochemistry 39, 12875-12884.
34. Lim, V.I. (1995) Analysis of action of the wobble adenine on codon reading within the ribosome. J Mol Biol 252, 277-282.
35. Maas, S., Gerber, A.P. & Rich, A. (1999) Identification and characterization of a human tRNA-specific adenosine deaminase related to the ADAR family of pre-mRNA editing enzymes. Proc Natl Acad Sci U S A 96, 8895-8900.
36. Marion, S., Weiner, D.M. & Caron, M.G. (2004) RNA editing induces variation in desensitization and trafficking of 5-hydroxytryptamine 2c receptor isoforms. J Biol Chem 279, 2945-2954.
37. Martinowich, K. & Lu, B. (2008) Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 33, 73-83.
38. McGrew, L., Price, R.D., Hackler, E., Chang, M.S. & Sanders-Bush, E. (2004) RNA editing of the human serotonin 5-HT2C receptor disrupts transactivation of the small G-protein RhoA. Mol Pharmacol 65, 252-256.
39. Meltzer, H. (1989) Serotonergic dysfunction in depression. Br J Psychiatry Suppl 8, 25-31.
40. Morabito, M.V., Abbas, A.I., Hood, J.L., Kesterson, R.A., Jacobs, M.M., Kump, D.S., Hachey, D.L., Roth, B.L. & Emeson, R.B. (2010a) Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader-Willi syndrome. Neurobiol Dis 39, 169-180.
41. Morabito, M.V., Ulbricht, R.J., O'Neil, R.T., Airey, D.C., Lu, P., Zhang, B., Wang, L. & Emeson, R.B. (2010b) High-throughput multiplexed transcript analysis yields enhanced resolution of 5-hydroxytryptamine 2C receptor mRNA editing profiles. Mol Pharmacol 77, 895-902.
42. Niswender, C.M., Herrick-Davis, K., Dilley, G.E., Meltzer, H.Y., Overholser, J.C., Stockmeier, C.A., Emeson, R.B. & Sanders-Bush, E. (2001) RNA editing of the human serotonin 5-HT2C receptor: alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology 24, 478-491.
43. Ohlson, J., Pedersen, J.S., Haussler, D. & Ohman, M. (2007) Editing modifies the GABA(A) receptor subunit alpha3. RNA 13, 698-703.
44. Pandey, G.N., Dwivedi, Y., Ren, X., Rizavi, H.S., Faludi, G., Sarosi, A. & Palkovits, M. (2006) Regional distribution and relative abundance of serotonin(2c) receptors in human brain: effect of suicide. Neurochem Res 31, 167-176.
45. Pilc, A., Chaki, S., Nowak, G. & Witkin, J.M. (2008) Mood disorders: regulation by metabotropic glutamate receptors. Biochem Pharmacol 75, 997-1006.
46. Price, R.D. & Sanders-Bush, E. (2000) RNA editing of the human serotonin 5-HT(2C) receptor delays agonist-stimulated calcium release. Mol Pharmacol 58, 859-862.
47. Price, R.D., Weiner, D.M., Chang, M.S. & Sanders-Bush, E. (2001) RNA editing of the human serotonin 5-HT2C receptor alters receptor-mediated activation of G13 protein. J Biol Chem 276, 44663-44668.
48. Qi, X., Lin, W., Li, J., Li, H., Wang, W., Wang, D. & Sun, M. (2008) Fluoxetine increases the activity of the ERK-CREB signal system and alleviates the depressive-like behavior in rats exposed to chronic forced swim stress. Neurobiol Dis 31, 278-285.
49. Rueter, S.M., Dawson, T.R. & Emeson, R.B. (1999) Regulation of alternative splicing by RNA editing. Nature 399, 75-80.
50. Scadden, A.D. (2007) Inosine-containing dsRNA binds a stress-granule-like complex and downregulates gene expression in trans. Mol Cell 28, 491-500.
51. Scadden, A.D. (2008) Gene expression is reduced in trans by inosine-containing dsRNA. Biochem Soc Trans 36, 534-536.
52. Schmauss, C. (2003) Serotonin 2C receptors: suicide, serotonin, and runaway RNA editing. Neuroscientist 9, 237-242.
53. Schmauss, C. & Howe, J.R. (2002) RNA editing of neurotransmitter receptors in the mammalian brain. Sci STKE 133, 26.
54. Seal, S.N., Schmidt, A. & Marcus, A. (1989) Ribosome binding to inosine-substituted mRNAs in the absence of ATP and mRNA factors. J Biol Chem 264, 7363-7368.
55. Shirayama, Y., Chen, A.C., Nakagawa, S., Russell, D.S. & Duman, R.S. (2002) Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22, 3251-3261.
56. Simmons, M., Meador-Woodruff, J.H. & Sodhi, M.S. (2010) Increased cortical expression of an RNA editing enzyme occurs in major depressive suicide victims. Neuroreport 21, 993-997.
57. Singh, M., Kesterson, R.A., Jacobs, M.M., Joers, J.M., Gore, J.C. & Emeson, R.B. (2007) Hyperphagia-mediated obesity in transgenic mice misexpressing the RNA-editing enzyme ADAR2. J Biol Chem 282, 22448-22459.
58. Singh, M., Zimmerman, M.B., Beltz, T.G. & Johnson, A.K. (2009) Affect-related behaviors in mice misexpressing the RNA editing enzyme ADAR2. Physiol Behav 97, 446-454.
59. Sodhi, M.S., Burnet, P.W., Makoff, A.J., Kerwin, R.W. & Harrison, P.J. (2001) RNA editing of the 5-HT(2C) receptor is reduced in schizophrenia. Mol Psychiatry 6, 373-379.
60. Sodhi, M.S., Airey, D.C., Lambert, W., Burnet, P.W., Harrison, P.J. & Sanders-Bush, E. (2005) A rapid new assay to detect RNA editing reveals antipsychotic-induced changes in serotonin-2C transcripts. Mol Pharmacol 68, 711-719.
61. Sommer, B., Kohler, M., Sprengel, R. & Seeburg, P.H. (1991) RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 67, 11-19.
62. Tohda, M., Nomura, M. & Nomura, Y. (2006) Molecular pathopharmacology of 5-HT2C receptors and the RNA editing in the brain. J Pharmacol Sci 100, 427-432.
63. Wang, Q., O'Brien, P.J., Chen, C.X., Cho, D.S., Murray, J.M. & Nishikura, K. (2000) Altered G protein-coupling functions of RNA editing isoform and splicing variant serotonin2C receptors. J Neurochem 74, 1290-1300.
64. Wang, Q., Miyakoda, M., Yang, W., Khillan, J., Stachura, D.L., Weiss, M.J. & Nishikura, K. (2004) Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J Biol Chem 279, 4952-4961.
65. Werry, T.D., Gregory, K.J., Sexton, P.M. & Christopoulos, A. (2005) Characterization of serotonin 5-HT2C receptor signaling to extracellular signal-regulated kinases 1 and 2. J Neurochem 93, 1603-1615.
66. Werry, T.D., Loiacono, R., Sexton, P.M. & Christopoulos, A. (2008a) RNA editing of the serotonin 5HT2C receptor and its effects on cell signalling, pharmacology and brain function. Pharmacol Ther 119, 7-23.
67. Werry, T.D., Stewart, G.D., Crouch, M.F., Watts, A., Sexton, P.M. & Christopoulos, A. (2008b) Pharmacology of 5HT(2C) receptor-mediated ERK1/2 phosphorylation: agonist-specific activation pathways and the impact of RNA editing. Biochem Pharmacol 76, 1276-1287.
68. Wong, S.K., Sato, S. & Lazinski, D.W. (2001) Substrate recognition by ADAR1 and ADAR2. RNA 7, 846-858.
69. Yang, W., Wang, Q., Kanes, S.J., Murray, J.M. & Nishikura, K. (2004) Altered RNA editing of serotonin 5-HT2C receptor induced by interferon: implications for depression associated with cytokine therapy. Brain Res Mol Brain Res 124, 70-78.
70. Ying, S.W., Futter, M., Rosenblum, K., Webber, M.J., Hunt, S.P., Bliss, T.V. & Bramham, C.R. (2002) Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: requirement for ERK activation coupled to CREB and upregulation of Arc synthesis. J Neurosci 22, 1532-1540.